Raymond James Financial’s Global X Funds Global X HealthTech ETF HEAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$271K Sell
9,828
-554
-5% -$14K ﹤0.01% 4876
2026
Q1
$247K Buy
10,382
+1,063
+11% +$28.9K ﹤0.01% 4767
2025
Q4
$272K Buy
9,319
+761
+9% +$23.7K ﹤0.01% 4640
2025
Q3
$274K Buy
8,558
+886
+12% +$28K ﹤0.01% 4461
2025
Q2
$251K Sell
7,672
-7,544
-50% -$228K ﹤0.01% 4399
2025
Q1
$431K Buy
15,216
+8,109
+114% +$255K ﹤0.01% 4020
2024
Q4
$210K Buy
+7,107
New +$211K ﹤0.01% 4382

Other funds holding HEAL

Raymond James Financial's HEAL Position: Q2 2026 in Review

Raymond James Financial reduced its Global X Funds Global X HealthTech ETF (HEAL) stake by 5.3% in Q2 2026, selling an estimated $14K and leaving 9,828 shares worth $271K. The position accounts for ﹤0.01% of the portfolio, ranked #4876.

Raymond James Financial first reported a position in HEAL in Q4 2024 and has held it in 7 quarters since. The position peaked at $431K in Q1 2025. 28 funds tracked by Wall St. Rank hold HEAL as of Q2 2026.

  • Raymond James Financial held 9,828 shares of Global X Funds Global X HealthTech ETF worth $271K as of Q2 2026.
  • Raymond James Financial sold 554 Global X Funds Global X HealthTech ETF shares in Q2 2026, an estimated $14K.
  • Global X Funds Global X HealthTech ETF made up ﹤0.01% of Raymond James Financial's portfolio in Q2 2026, its #4876 holding.
  • Raymond James Financial first reported a position in Global X Funds Global X HealthTech ETF in Q4 2024 and has held it in 7 quarters since.
  • Raymond James Financial's Global X Funds Global X HealthTech ETF position peaked at $431K in Q1 2025.
  • 28 funds tracked by Wall St. Rank held Global X Funds Global X HealthTech ETF as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.